The University has received a limited supply of the newly-developed H1N1 vaccine and will distribute the vaccine Friday to people determined to be at the highest risk, Director of Internal Communications Gail Mancini said.
Mancini said University Health Services has about 500 doses of the vaccine for students, faculty and staff, which will be first given to pregnant women, people under the age of 25 who have chronic health problems as determined by the Center for Disease Control (CDC).
Some of the health problems outlined include cancer, asthma and diabetes.
The vaccine will be distributed Friday in Stepan Center from 10 a.m. to 2 p.m.
As more of the vaccine becomes available, Health Services will expand the groups eligible to receive the vaccine.
The Observer reported Wednesday that there have been 659 presumed cases of the H1N1 virus, commonly referred to as swine flu, at Notre Dame since August.
More information can be found at the University Health Services Web site.
